Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

DC Comics once published a series called The War That Time Forgot, notable for weak writing and terrific art — and, most of all, for great cover images of World War II GIs battling dinosaurs.

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

A blast of feedback, squealing from overdriven tube amps the moment the guitarist unmutes their signal chain, is the simplest way to capture the raw live feel of an extreme metal show on record. While ...

Virginia Beach-based Born Primitive is bringing its patriot-inspired workout apparel to the Hilltop shopping district. The e-commerce clothing brand, co-founded in a garage in 2014 by former Navy SEAL ...

Recursion said it will end development for four of its 11 pipeline programs—one of which the company will consider outlicensing to a partner instead—and pause a fifth program, in a pruning designed to ...